Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1984-09

AUTHORS

J. W. Ward, A. McBurney, P. R. Farrow, P. Sharp

ABSTRACT

Preliminary investigation in 3 healthy volunteers suggested that intravenous pinacidil in a dose of 0.2 mg/kg had a potent but well-tolerated hypotensive action in the supine position. Facial flushing, uncomfortable chest sensation and distressing postural hypotension occurred at serum concentrations above 300 ng/ml. Pinacidil, 0.2 mg/kg, was given intravenously over 4 min to 15 healthy volunteers in the supine position. Maximum fall in mean arterial pressure (MAP) was 15.7±6.0 mmHg. Maximum rise in heart rate was 23.8±6.6 beats/min. Pinacidil serum distribution half-life (\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document} $${\text{T}}_{{\raise0.7ex\hbox{${\text{1}}$} \!\mathord{\left/ {\vphantom {{\text{1}} {{\text{2}}\alpha }}}\right.\kern-\nulldelimiterspace}\!\lower0.7ex\hbox{${{\text{2}}\alpha }$}}}$$ \end{document}) was 13.4±8.5 min and elimination half-life (\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document} $${\text{T}}_{{\raise0.7ex\hbox{${\text{1}}$} \!\mathord{\left/ {\vphantom {{\text{1}} {{\text{2}}\beta }}}\right.\kern-\nulldelimiterspace}\!\lower0.7ex\hbox{${{\text{2}}\beta }$}}}$$ \end{document}) was 2.13±0.49 h. The apparent volume of distribution (Vdβ) was 90.3±13.21 and total body clearance was 31.1±9.61/h. Pinacidil was approximately 40% bound to plasma protein over the concentration range 40–400 ng/ml. Urinary excretion of unchanged pinacidil accounted for 5.7 ± 1.3% of the administered dose over 24 hours and urinary excretion of the major metabolite, pinacidil pyridine-N-oxide, was 31.6±9.2% of the administered dose. It was concluded that intravenous pinacidil is a potent vasodilator hypotensive compound, with a duration of action between 1.5 and 2 h. More... »

PAGES

603-608

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00543493

DOI

http://dx.doi.org/10.1007/bf00543493

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1043833646

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/6468476


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antihypertensive Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Pressure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Guanidines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kinetics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pinacidil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Posture", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vasodilator Agents", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacology Groby Road Hospital Leicester, England", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Clinical Pharmacology Groby Road Hospital Leicester, England"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ward", 
        "givenName": "J. W.", 
        "id": "sg:person.0675422255.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675422255.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacology Groby Road Hospital Leicester, England", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Clinical Pharmacology Groby Road Hospital Leicester, England"
          ], 
          "type": "Organization"
        }, 
        "familyName": "McBurney", 
        "givenName": "A.", 
        "id": "sg:person.0743535455.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743535455.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacology Groby Road Hospital Leicester, England", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Clinical Pharmacology Groby Road Hospital Leicester, England"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Farrow", 
        "givenName": "P. R.", 
        "id": "sg:person.01011650655.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01011650655.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacology Groby Road Hospital Leicester, England", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Clinical Pharmacology Groby Road Hospital Leicester, England"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sharp", 
        "givenName": "P.", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/clpt.1980.234", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033747726", 
          "https://doi.org/10.1038/clpt.1980.234"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00562058", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036861154", 
          "https://doi.org/10.1007/bf00562058"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01975139", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036141189", 
          "https://doi.org/10.1007/bf01975139"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/clpt.1981.40", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048755408", 
          "https://doi.org/10.1038/clpt.1981.40"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1984-09", 
    "datePublishedReg": "1984-09-01", 
    "description": "Preliminary investigation in 3 healthy volunteers suggested that intravenous pinacidil in a dose of 0.2 mg/kg had a potent but well-tolerated hypotensive action in the supine position. Facial flushing, uncomfortable chest sensation and distressing postural hypotension occurred at serum concentrations above 300 ng/ml. Pinacidil, 0.2 mg/kg, was given intravenously over 4 min to 15 healthy volunteers in the supine position. Maximum fall in mean arterial pressure (MAP) was 15.7\u00b16.0 mmHg. Maximum rise in heart rate was 23.8\u00b16.6 beats/min. Pinacidil serum distribution half-life (\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym}\n\t\t\t\t\\usepackage{amsfonts}\n\t\t\t\t\\usepackage{amssymb}\n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}\n$${\\text{T}}_{{\\raise0.7ex\\hbox{${\\text{1}}$} \\!\\mathord{\\left/ {\\vphantom {{\\text{1}} {{\\text{2}}\\alpha }}}\\right.\\kern-\\nulldelimiterspace}\\!\\lower0.7ex\\hbox{${{\\text{2}}\\alpha }$}}}$$\n\\end{document}) was 13.4\u00b18.5 min and elimination half-life (\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym}\n\t\t\t\t\\usepackage{amsfonts}\n\t\t\t\t\\usepackage{amssymb}\n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}\n$${\\text{T}}_{{\\raise0.7ex\\hbox{${\\text{1}}$} \\!\\mathord{\\left/ {\\vphantom {{\\text{1}} {{\\text{2}}\\beta }}}\\right.\\kern-\\nulldelimiterspace}\\!\\lower0.7ex\\hbox{${{\\text{2}}\\beta }$}}}$$\n\\end{document}) was 2.13\u00b10.49 h. The apparent volume of distribution (Vd\u03b2) was 90.3\u00b113.21 and total body clearance was 31.1\u00b19.61/h. Pinacidil was approximately 40% bound to plasma protein over the concentration range 40\u2013400 ng/ml. Urinary excretion of unchanged pinacidil accounted for 5.7 \u00b1 1.3% of the administered dose over 24 hours and urinary excretion of the major metabolite, pinacidil pyridine-N-oxide, was 31.6\u00b19.2% of the administered dose. It was concluded that intravenous pinacidil is a potent vasodilator hypotensive compound, with a duration of action between 1.5 and 2 h.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/bf00543493", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1054337", 
        "issn": [
          "0031-6970", 
          "1432-1041"
        ], 
        "name": "European Journal of Clinical Pharmacology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "26"
      }
    ], 
    "keywords": [
      "mean arterial pressure", 
      "healthy volunteers", 
      "urinary excretion", 
      "supine position", 
      "pinacidil pyridine-N-oxide", 
      "new potent vasodilator", 
      "total body clearance", 
      "beats/min", 
      "duration of action", 
      "chest sensations", 
      "postural hypotension", 
      "hypotensive action", 
      "arterial pressure", 
      "hypotensive effect", 
      "serum concentrations", 
      "body clearance", 
      "potent vasodilator", 
      "heart rate", 
      "maximum fall", 
      "pinacidil", 
      "apparent volume", 
      "serum distribution", 
      "hypotensive compounds", 
      "major metabolite", 
      "dose", 
      "volunteers", 
      "excretion", 
      "min", 
      "maximum rise", 
      "hypotension", 
      "vasodilators", 
      "mmHg", 
      "pharmacokinetics", 
      "clearance", 
      "sensation", 
      "duration", 
      "action", 
      "hours", 
      "metabolites", 
      "concentration", 
      "fall", 
      "preliminary investigation", 
      "protein", 
      "elimination", 
      "rate", 
      "effect", 
      "volume", 
      "pressure", 
      "investigation", 
      "rise", 
      "compounds", 
      "position", 
      "distribution", 
      "pyridine N-oxide"
    ], 
    "name": "Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator", 
    "pagination": "603-608", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1043833646"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00543493"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "6468476"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00543493", 
      "https://app.dimensions.ai/details/publication/pub.1043833646"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:18", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_175.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/bf00543493"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00543493'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00543493'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00543493'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00543493'


 

This table displays all metadata directly associated to this object as RDF triples.

195 TRIPLES      21 PREDICATES      95 URIs      83 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00543493 schema:about N00ba14a6deea43708296dbc2e92c2254
2 N02de1ef8f64445ca9e3f61226c925800
3 N0a0f5dda33354f0fbb54f569af9ca9ac
4 N43a97a36c65e44719c0a05570b37463e
5 N481479d0550d46b58747ab1779dd3b06
6 N862c300461a940ed873f738b3e912c1f
7 N9b5face2e89d40d9afab2de75b62e8af
8 N9c45c5b0cf0b490cbac572c5df317de9
9 Na118382674194e5b88078265754eba31
10 Na9071667c0fe4cdd836a938c233497c3
11 Nbfe65af76ec64c9f85106b41cfd17707
12 anzsrc-for:11
13 anzsrc-for:1103
14 schema:author N2304ed2093524181b8ef14f3632e3a79
15 schema:citation sg:pub.10.1007/bf00562058
16 sg:pub.10.1007/bf01975139
17 sg:pub.10.1038/clpt.1980.234
18 sg:pub.10.1038/clpt.1981.40
19 schema:datePublished 1984-09
20 schema:datePublishedReg 1984-09-01
21 schema:description Preliminary investigation in 3 healthy volunteers suggested that intravenous pinacidil in a dose of 0.2 mg/kg had a potent but well-tolerated hypotensive action in the supine position. Facial flushing, uncomfortable chest sensation and distressing postural hypotension occurred at serum concentrations above 300 ng/ml. Pinacidil, 0.2 mg/kg, was given intravenously over 4 min to 15 healthy volunteers in the supine position. Maximum fall in mean arterial pressure (MAP) was 15.7±6.0 mmHg. Maximum rise in heart rate was 23.8±6.6 beats/min. Pinacidil serum distribution half-life (\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document} $${\text{T}}_{{\raise0.7ex\hbox{${\text{1}}$} \!\mathord{\left/ {\vphantom {{\text{1}} {{\text{2}}\alpha }}}\right.\kern-\nulldelimiterspace}\!\lower0.7ex\hbox{${{\text{2}}\alpha }$}}}$$ \end{document}) was 13.4±8.5 min and elimination half-life (\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document} $${\text{T}}_{{\raise0.7ex\hbox{${\text{1}}$} \!\mathord{\left/ {\vphantom {{\text{1}} {{\text{2}}\beta }}}\right.\kern-\nulldelimiterspace}\!\lower0.7ex\hbox{${{\text{2}}\beta }$}}}$$ \end{document}) was 2.13±0.49 h. The apparent volume of distribution (Vdβ) was 90.3±13.21 and total body clearance was 31.1±9.61/h. Pinacidil was approximately 40% bound to plasma protein over the concentration range 40–400 ng/ml. Urinary excretion of unchanged pinacidil accounted for 5.7 ± 1.3% of the administered dose over 24 hours and urinary excretion of the major metabolite, pinacidil pyridine-N-oxide, was 31.6±9.2% of the administered dose. It was concluded that intravenous pinacidil is a potent vasodilator hypotensive compound, with a duration of action between 1.5 and 2 h.
22 schema:genre article
23 schema:isAccessibleForFree false
24 schema:isPartOf N6082e46615d24ea2966436397f33ed85
25 Na6cb0eb1409f4739af6473ccdccb7095
26 sg:journal.1054337
27 schema:keywords action
28 apparent volume
29 arterial pressure
30 beats/min
31 body clearance
32 chest sensations
33 clearance
34 compounds
35 concentration
36 distribution
37 dose
38 duration
39 duration of action
40 effect
41 elimination
42 excretion
43 fall
44 healthy volunteers
45 heart rate
46 hours
47 hypotension
48 hypotensive action
49 hypotensive compounds
50 hypotensive effect
51 investigation
52 major metabolite
53 maximum fall
54 maximum rise
55 mean arterial pressure
56 metabolites
57 min
58 mmHg
59 new potent vasodilator
60 pharmacokinetics
61 pinacidil
62 pinacidil pyridine-N-oxide
63 position
64 postural hypotension
65 potent vasodilator
66 preliminary investigation
67 pressure
68 protein
69 pyridine N-oxide
70 rate
71 rise
72 sensation
73 serum concentrations
74 serum distribution
75 supine position
76 total body clearance
77 urinary excretion
78 vasodilators
79 volume
80 volunteers
81 schema:name Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator
82 schema:pagination 603-608
83 schema:productId N6433c80784384df4888473c7e7a33c0e
84 Nb3fa3eeeb8d34350ab82402c0e9cfbc2
85 Nd098539f656344c9ac4eb04b642a3e5b
86 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043833646
87 https://doi.org/10.1007/bf00543493
88 schema:sdDatePublished 2022-12-01T06:18
89 schema:sdLicense https://scigraph.springernature.com/explorer/license/
90 schema:sdPublisher N4d54bdef55294f60a79f8a280125844e
91 schema:url https://doi.org/10.1007/bf00543493
92 sgo:license sg:explorer/license/
93 sgo:sdDataset articles
94 rdf:type schema:ScholarlyArticle
95 N00ba14a6deea43708296dbc2e92c2254 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Posture
97 rdf:type schema:DefinedTerm
98 N02de1ef8f64445ca9e3f61226c925800 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Pinacidil
100 rdf:type schema:DefinedTerm
101 N0a0f5dda33354f0fbb54f569af9ca9ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Humans
103 rdf:type schema:DefinedTerm
104 N2304ed2093524181b8ef14f3632e3a79 rdf:first sg:person.0675422255.52
105 rdf:rest N84c247ae30d04d7887101b85c1033422
106 N38e5e0f7dd424ae58acfa668a2cff6bc schema:affiliation grid-institutes:None
107 schema:familyName Sharp
108 schema:givenName P.
109 rdf:type schema:Person
110 N43a97a36c65e44719c0a05570b37463e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Guanidines
112 rdf:type schema:DefinedTerm
113 N481479d0550d46b58747ab1779dd3b06 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Adult
115 rdf:type schema:DefinedTerm
116 N4d54bdef55294f60a79f8a280125844e schema:name Springer Nature - SN SciGraph project
117 rdf:type schema:Organization
118 N6082e46615d24ea2966436397f33ed85 schema:issueNumber 5
119 rdf:type schema:PublicationIssue
120 N6433c80784384df4888473c7e7a33c0e schema:name pubmed_id
121 schema:value 6468476
122 rdf:type schema:PropertyValue
123 N7ddfe8a7a04048138835d19a1a7ed588 rdf:first N38e5e0f7dd424ae58acfa668a2cff6bc
124 rdf:rest rdf:nil
125 N84c247ae30d04d7887101b85c1033422 rdf:first sg:person.0743535455.00
126 rdf:rest N92f3e7bdc76540b694dfb9c78dca5fe9
127 N862c300461a940ed873f738b3e912c1f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Heart Rate
129 rdf:type schema:DefinedTerm
130 N92f3e7bdc76540b694dfb9c78dca5fe9 rdf:first sg:person.01011650655.66
131 rdf:rest N7ddfe8a7a04048138835d19a1a7ed588
132 N9b5face2e89d40d9afab2de75b62e8af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Blood Pressure
134 rdf:type schema:DefinedTerm
135 N9c45c5b0cf0b490cbac572c5df317de9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Vasodilator Agents
137 rdf:type schema:DefinedTerm
138 Na118382674194e5b88078265754eba31 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Male
140 rdf:type schema:DefinedTerm
141 Na6cb0eb1409f4739af6473ccdccb7095 schema:volumeNumber 26
142 rdf:type schema:PublicationVolume
143 Na9071667c0fe4cdd836a938c233497c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Kinetics
145 rdf:type schema:DefinedTerm
146 Nb3fa3eeeb8d34350ab82402c0e9cfbc2 schema:name dimensions_id
147 schema:value pub.1043833646
148 rdf:type schema:PropertyValue
149 Nbfe65af76ec64c9f85106b41cfd17707 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Antihypertensive Agents
151 rdf:type schema:DefinedTerm
152 Nd098539f656344c9ac4eb04b642a3e5b schema:name doi
153 schema:value 10.1007/bf00543493
154 rdf:type schema:PropertyValue
155 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
156 schema:name Medical and Health Sciences
157 rdf:type schema:DefinedTerm
158 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
159 schema:name Clinical Sciences
160 rdf:type schema:DefinedTerm
161 sg:journal.1054337 schema:issn 0031-6970
162 1432-1041
163 schema:name European Journal of Clinical Pharmacology
164 schema:publisher Springer Nature
165 rdf:type schema:Periodical
166 sg:person.01011650655.66 schema:affiliation grid-institutes:None
167 schema:familyName Farrow
168 schema:givenName P. R.
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01011650655.66
170 rdf:type schema:Person
171 sg:person.0675422255.52 schema:affiliation grid-institutes:None
172 schema:familyName Ward
173 schema:givenName J. W.
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675422255.52
175 rdf:type schema:Person
176 sg:person.0743535455.00 schema:affiliation grid-institutes:None
177 schema:familyName McBurney
178 schema:givenName A.
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743535455.00
180 rdf:type schema:Person
181 sg:pub.10.1007/bf00562058 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036861154
182 https://doi.org/10.1007/bf00562058
183 rdf:type schema:CreativeWork
184 sg:pub.10.1007/bf01975139 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036141189
185 https://doi.org/10.1007/bf01975139
186 rdf:type schema:CreativeWork
187 sg:pub.10.1038/clpt.1980.234 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033747726
188 https://doi.org/10.1038/clpt.1980.234
189 rdf:type schema:CreativeWork
190 sg:pub.10.1038/clpt.1981.40 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048755408
191 https://doi.org/10.1038/clpt.1981.40
192 rdf:type schema:CreativeWork
193 grid-institutes:None schema:alternateName Department of Clinical Pharmacology Groby Road Hospital Leicester, England
194 schema:name Department of Clinical Pharmacology Groby Road Hospital Leicester, England
195 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...